Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.
$4.43B
FY2025 · ▲ 5.8% vs FY2024
| Fiscal year | Year end | Deferred Tax Assets, in Process Research and Development, by fiscal year |
|---|---|---|
| FY2025 | Dec 31, 2025 | $4,426,000,000 |
| FY2024 | Dec 31, 2024 | $4,185,000,000 |
| FY2023 | Dec 31, 2023 | $3,524,000,000 |
| FY2022 | Dec 31, 2022 | $3,012,000,000 |
| FY2021 | Dec 31, 2021 | $2,161,000,000 |
| FY2020 | Dec 31, 2020 | $1,387,000,000 |
| FY2019 | Dec 31, 2019 | $722,000,000 |
| FY2011 | Dec 31, 2011 | $70,000,000 |
| FY2010 | Dec 31, 2010 | $291,000,000 |
| FY2009 | Dec 31, 2009 | $539,000,000 |
| Period | Length | Value | Last reported | Filings |
|---|---|---|---|---|
| Dec 31, 2025 | As of date | $4,426,000,000 | Feb 24, 2026 | 1 |
| Dec 31, 2024 | As of date | $4,185,000,000 | Feb 24, 2026 | 2 |
| Dec 31, 2023 | As of date | $3,524,000,000 | Feb 25, 2025 | 2 |
| Dec 31, 2022 | As of date | $3,012,000,000 | Feb 26, 2024 | 2 |
| Dec 31, 2021 | As of date | $2,161,000,000 | Feb 28, 2023 | 2 |
| Dec 31, 2020 |
| As of date |
| $1,387,000,000 |
| Feb 22, 2022 |
| 2 |
| Dec 31, 2019 | As of date | $722,000,000 | Feb 23, 2021 | 2 |
| Dec 31, 2011 | As of date | $70,000,000 | Feb 28, 2012 | 1 |
| Dec 31, 2010 | As of date | $291,000,000 | Feb 28, 2012 | 2 |
| Dec 31, 2009 | As of date | $539,000,000 | Feb 22, 2011 | 1 |